# Safety and Efficacy of CEA-targeted CAR-T for CEA-positive Advanced Malignant Solid Tumors

> clinical trial · VERIFIED · 2026-07-10

Status: COMPLETED · Sponsor: Chongqing Precision Biotech Co., Ltd · Condition: Gastric Cancer

- Company: Chongqing Precision Biotech Co., Ltd
- Sector: Gastric Cancer
- Primary source: https://clinicaltrials.gov/study/NCT05538195

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.